Suscribirse

Predictive modeling for chronic pain after ventral hernia repair - 24/08/16

Doi : 10.1016/j.amjsurg.2016.02.021 
Tiffany C. Cox, M.D., Ciara R. Huntington, M.D., Laurel J. Blair, M.D., Tanushree Prasad, M.A., Amy E. Lincourt, M.B.A, Ph.D., Brant T. Heniford, M.D., F.A.C.S. , Vedra A. Augenstein, M.D., F.A.C.S.
 Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Laparoscopic and Advanced Surgery Program, Carolinas Medical Center, Charlotte, NC, USA 

Corresponding author. Tel.: (704) 355-3168; fax: (704) 355-4117.

Abstract

Background

Few studies predict which patients have dissolution of their postoperative discomfort or develop chronic pain after ventral hernia repair (VHR). This study develops a predictive model to determine which patients are at the greatest risk of chronic pain after VHR.

Methods

A prospective study of VHR patients was performed via the International Hernia Mesh Registry. Anonymous, self-reported, quality of life data using the Carolinas Comfort Scale (CCS) was recorded preoperatively, and 1,6, and 12 months postoperatively. Pain was identified as a score of 2 or more (mild but bothersome to severe) for any Carolinas Comfort Scale pain-specific questions. Logistic regression analyses were performed to determine statistically significant predictors of chronic pain. Univariate analysis selected potential predictors with a P value less than .15, and a subsequent multivariable model was built using backward elimination setting retention criterion at P < .15. Goodness-of-fit of the model was tested using Hosmer-Lemeshow test. A value of greater than 70% for the area under the curve (AUC) was considered most accurate diagnostically. The final model was then internally validated with bootstrap analysis.

Results

A total of 887 patients underwent VHR between 2007 and 2014. The patients had an average age of 57.2 ± 12.8 years, 52.4% were female, 17.0% were active smokers, and 13.2% used narcotics preoperatively. With 74% follow-up at 1 year, 26.0% of the patients reported chronic discomfort. After logistic regression model, independent predictors of pain at 6 months were preoperative pain score 2 or more (P < .0001), preoperative narcotic use (P = .06), and 1-month postoperative pain score 2 or more (P < .0001), AUC = .74. Baseline, 1-month, and 6-month predictors determined the final multivariate regression model for prediction of chronic pain at 1 year, AUC = .73. Older age was protective against chronic pain (odds ratio [OR] .98, 95%confidence interval [CI] = .96 to .998, P = .03), female sex increased risk with an OR of 1.7(CI = 1.1 to 2.7, P = .02); preoperative pain, and recurrent hernia repair nearly doubled the risk of developing chronic pain postoperatively (OR = 3.0, CI = 1.8 to 4.8, P < .0001 and 1.6, CI = .98 to 2.6, P = .06, respectively). Importantly, presence of pain at 1 month was a strong predictor of chronic pain at 1-year follow-up (OR = 2.6, CI = 1.7 to 4.2, P < .0001).

Conclusions

Patients who have preoperative pain and at 1 month postoperatively are significantly more likely to have chronic pain. Both short- and long-term pain can be predicted from female sex, younger age, and repair of recurrent hernias. This predictive model may aid in preoperative counseling and when considering postoperative intervention for pain management in VHR patients.

El texto completo de este artículo está disponible en PDF.

Highlights

This prospective international database is registered at www.clinicaltrials.gov.
This model identified factors predicting chronic pain after ventral hernia repair.
Younger age, females, recurrent hernia repair, and preop pain predict 1-month pain.
Younger age, females, and preop pain predict 6-month and 12-month chronic pain.
This predictive model can aid in preop counseling and early postop management.

El texto completo de este artículo está disponible en PDF.

Keywords : Ventral hernia, Quality of life, Predictive model, Carolinas Comfort Scale, Predict, Pain


Esquema


 There were no relevant financial relationships or any sources of support in the form of grants, equipment, or drugs.
 B.T.H., A.E.L., and V.A. have previously been awarded surgical research and education grants and honoraria from W.L. Gore and Associates, Ethicon, Novadaq, Bard/Davol, and LifeCell Inc. T.C., C.H., L.B., and T.P. have no potential conflicts or disclosures relevant to this work.


© 2016  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 212 - N° 3

P. 501-510 - septembre 2016 Regresar al número
Artículo precedente Artículo precedente
  • Unplanned readmission after appendectomy
  • Zhobin Moghadamyeghaneh, Grace Hwang, Mark H. Hanna, Joseph C. Carmichael, Steven Mills, Alessio Pigazzi, Michael J. Stamos
| Artículo siguiente Artículo siguiente
  • Extralevator vs conventional abdominoperineal resection for rectal cancer—A systematic review and meta-analysis
  • Ionut Negoi, Sorin Hostiuc, Sorin Paun, Ruxandra I. Negoi, Mircea Beuran

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.